title: Shock Reduction With Long-Term Quinidine in Patients With Brugada Syndrome and Malignant Ventricular Arrhythmia Episodes.
authors.forename: Ignasi
authors.initials: I
authors.lastname: Anguera
authors.forename: Arcadio
authors.initials: A
authors.lastname: García-Alberola
authors.forename: Paolo
authors.initials: P
authors.lastname: Dallaglio
authors.forename: Jorge
authors.initials: J
authors.lastname: Toquero
authors.forename: Luisa
authors.initials: L
authors.lastname: Pérez
authors.forename: Juan Gabriel
authors.initials: JG
authors.lastname: Martínez
authors.forename: Rafael
authors.initials: R
authors.lastname: Peinado
authors.forename: José M
authors.initials: JM
authors.lastname: Rubín
authors.forename: Josep
authors.initials: J
authors.lastname: Brugada
authors.forename: Angel
authors.initials: A
authors.lastname: Cequier
mesh_terms: D000277:Adjuvants, Pharmaceutic / Q000008:administration & dosage / Q000009:adverse effects; D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects; D053840:Brugada Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D017147:Defibrillators, Implantable / Q000009:adverse effects; D004554:Electric Countershock / Q000009:adverse effects / Q000379:methods; D004562:Electrocardiography / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care; D011802:Quinidine / Q000008:administration & dosage / Q000009:adverse effects; D013030:Spain / Q000453:epidemiology; D014693:Ventricular Fibrillation / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control
chemical_list: D000277:Adjuvants, Pharmaceutic; D000889:Anti-Arrhythmia Agents; D011802:Quinidine